Ever more scientists are joining drug companies' sales departments. Are they happy there? Marika Willerroider investigates.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Related links
Related links
Related links in Nature Research
Making the switch from science to business
Making the move from physics to finance
Science and Law: Swapping the lab for the law
Making the move into science policy
Related external links
Rights and permissions
About this article
Cite this article
Willerroider, M. Making the move into drug sales. Nature 430, 486–487 (2004). https://doi.org/10.1038/nj6998-486a
Published:
Issue Date:
DOI: https://doi.org/10.1038/nj6998-486a
This article is cited by
-
Movers
Nature (2005)
-
Job movements
Nature (2005)
